Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × disitamab vedotin × Clear all

NCT06155396 2024-02-28

A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms